3D Printed Bladder Cancer Mimic for In Vivo Environment Replication
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional two-dimensional bladder cancer models lack the tumor microenvironment and are time-consuming and less accurate compared to in vivo responses, necessitating a more sophisticated and efficient model for bladder cancer research and treatment development.
Innovation Solution
A three-dimensional bladder cancer mimic comprising a stacked structure of endothelial, fibroblast, and bladder cancer cell layers, produced via 3D printing, which accurately reflects the in vivo environment and can be used in a lab-on-a-chip for substance screening.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If planar cancer models are used for bladder cancer research, then the model establishment is simple, but the model lacks tumor microenvironment and cannot accurately reflect in vivo responses
Solution Approach 1:
The patent transitions from two-dimensional planar cell culture models to three-dimensional microfluidic organoid models. This dimensional change enables the incorporation of multiple cell types (cancer cells, fibroblasts, endothelial cells) in a spatially organized stacked structure that mimics the tumor microenvironment, thereby improving model reliability while maintaining ease of manufacture through standardized microfluidic fabrication processes
Solution Approach 2:
The patent creates a nested multi-layer structure where different cell types are organized in stacked layers within the microfluidic device. The cancer cell layer, fibroblast layer, and endothelial cell layer are nested in a specific spatial arrangement that reproduces the hierarchical organization of the tumor microenvironment, allowing accurate reflection of in vivo interactions
2Reliability
If mouse models are used to produce bladder cancer models, then the tumor microenvironment can be reflected, but the model production time is long and species differences remain
Solution Approach 1:
The patent creates a simplified human-relevant copy of the tumor microenvironment using human-derived cells in a microfluidic device. Instead of using complex animal models, the invention copies the essential functional elements of the tumor microenvironment (cancer cells, stromal cells, vascular components) in a reduced-scale human-specific system that provides results faster while maintaining physiological relevance
Solution Approach 2:
The patent extracts the key functional components of the tumor microenvironment (cancer cells, fibroblasts, endothelial cells) and isolates them in a controlled microfluidic environment. By taking out only the essential elements needed to study tumor-stroma-vascular interactions, the model achieves rapid establishment without the time-consuming process of generating full animal models
3Ease of manufacture
If conventional 3D cell culture technology using pipette is used, then the structure formation is possible, but the structure sophistication is limited
Solution Approach 1:
The patent replaces manual pipetting operations with automated 3D bioprinting technology. This substitution enables precise deposition of cells and biomaterials in predetermined three-dimensional patterns, creating sophisticated hierarchical structures with controlled spatial arrangement of different cell types that cannot be achieved through conventional manual techniques
Solution Approach 2:
The patent employs composite biomaterials including gelatin methacryloyl (GelMA) and other hydrogels that provide structural support while supporting cell viability. These composite materials enable the formation of sophisticated 3D structures with tuned mechanical and biological properties, allowing complex multi-layer architectures to be maintained while supporting diverse cell populations
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The 3D bladder cancer mimic and lab-on-a-chip provide a more accurate and efficient platform for screening bladder cancer treatments, allowing for the development of both general and patient-specific therapeutic agents, surpassing the limitations of traditional models.
Implementation Method 1
3D printers have been applied in various fields due to their broad-spectrum applicability, and in recent years, technology of forming a structure by printing cells has been studied
Implementation Method 2
A cell-friendly 3D cell structure may be formed using gelatin methacrylate which is harmless to cells
Data Source
AI summary
A microfluidic bladder cancer mimic and the use thereof is provided. The bladder cancer mimic is produced through 3D printing, which may more accurately reflect in vivo environments than conventional two-dimensional cell models and may be more simply produced than animal models. A method of screening bladder cancer treatment substances using a lab-on-a-chip including the bladder cancer mimic that may be used for the development of anticancer therapeutic agents and may also be used to develop patient-specific therapeutic agents by using patient-derived bladder cancer cells.